For press inquiries click here to contact us.
Alumis, Inc.
Foresite’s immunology play gets a $200M megaround for TYK2 program, rebranding as Alumis
Detect, Inc.
As Omicron Spreads, New PCR-Like At-Home Covid Tests Provide Fast, Accurate Results
ImmPACT Bio, Inc.
Novartis-backed ImmPACT Bio snags $111M and new CEO as cancer CAR-T yields phase 1 results
Eikon Therapeutics
‘How can you understand life if you don’t look at it live?’ — Eikon Therapeutics rakes in $518M
Bit Bio Limited
This Startup Is Making—and Programming—Human Cells
Everly Health
EXCLUSIVE: The parent company of home-health testing brand Everlywell is buying Natalist, a reproductive health startup
Evonetix
Evonetix granted patent for DNA data storage and retrieval method
Alumis, Inc.
Esker Therapeutics snags former Principia CEO in hiring spree
Cue Health
With Cue Health IPO On Tap, Other Startups With COVID Tests Are Also Scaling
Please see important disclaimers in the Terms section.
